Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma

Table 2 LncRNA DLX6-AS1 and DLX6 mRNA expression levels were associated with clinicopathological features of LAC Patients

Clinicopathological factor	n	LncRNA DLX6-AS1 expression (2 ^–ΔCt )		DLX6 mRNA expression(2 ^–ΔCt )
Clinicopathological factor	n	Median ± SD	P- Vale	Media ± SD	P -Value
Gender
Male	35	0.6452±0.1905	0.249	2.5103±0.4123	0.149
Female	37	0.6926±0.1541		2.6941±0.6363
Age (years)
≥60	34	0.6762±0.1837	0.762	2.6426±0.6820	0.591
<60	38	0.6637±0.1655		2.5709±0.3863
Differentiation
Well	27	0.5965±0.2017	0.004*	2.2947±0.3855	0.000*
Moderate	33	0.6873±0.1510	0.004*	2.7153±0.5559	0.000*
Poor	12	0.7852±0.4988		2.9984±0.4624
Lymph node metastasis
Positive	33	0.7078±0.1259	0.075	2.7230±0.5027	0.087
Negative	39	0.6373±0.2009		2.5047±0.5625
TNM stage
I	18	0.5806±0.1533	0.033*	2.3290±0.3853	0.001*
II	36	0.6897±0.1806		2.5641±0.4939
III	18	0.7184±0.1512		2.9618±0.6028

ISSN: 1475-2867